TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
GEVO

Gevo Inc

Basic Materials · Specialty Chemicals

1.30$ +1.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Gevo Inc (GEVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 491 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GEVO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
116 112 105 97 94 89 83 116 111 107 111 104 95 93 84 80 153 152 609 686 675 645 639 775 729 701 689 675 670 650 634 618 604 584 678 702 685 719 654 491
36 33 27 23 21 18 13 48 43 39 42 34 26 24 16 13 88 83 534 329 361 349 335 485 432 415 386 429 411 386 282 258 237 204 104 170 137 143 116 102
31 28 20 16 15 12 7.0 27 38 34 35 29 21 16 9.3 6.3 81 78 525 17 16 41 45 173 201 237 342 348 324 298 271 246 223 189 65 57 73 81 79 58
31 28 20 16 15 12 7.0 27 38 34 35 29 21 16 9.3 6.3 81 78 525 264 301 316 310 471 423 405 375 348 324 298 271 246 223 189 65 57 73 81 79 58
1.1 1.1 1.2 1.4 1.2 1.1 1.3 16 0.7 0.5 1.1 0.2 0.4 1.1 0.2 0.7 0.4 0.5 0.1 0.8 0.5 1.0 0.2 0.2 0.4 0.5 0.9 1.0 2.2 4.0 3.7 3.3 2.3 3.1 12 16 7.9 9.4 11 17
3.2 3.5 4.2 4.3 4.3 4.4 4.4 3.8 3.3 3.2 3.2 3.3 3.0 3.2 2.7 2.5 2.6 2.5 2.5 2.2 2.3 2.8 2.7 2.6 4.1 6.3 4.4 4.4 3.7 3.8 3.8 3.4 5.8 4.5 17 17 22 19 22 19
77 76 75 73 72 70 69 67 67 67 68 68 68 67 66 65 63 67 71 109 131 139 157 206 166 177 184 199 240 – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – 0.0 – – 3.7 3.7 42 44 44 44 44 44
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – 0.1 – – 9.1 8.9 8.7 8.4 8.0 7.7 7.4 7.1 6.8 6.5 6.2 5.9 8.5 8.1 52 70 80 95 60 72
49 43 28 29 27 25 21 16 18 18 19 18 19 21 20 20 19 5.7 13 110 116 98 104 111 104 95 95 91 98 93 92 95 99 94 203 222 210 248 199 210
40 35 26 16 14 11 7.3 4.3 5.6 5.3 18 18 18 20 19 19 18 4.9 11 21 27 29 18 26 18 25 26 90 96 91 22 25 29 24 51 73 72 79 27 38
25 26 17 8.6 6.5 5.2 2.4 0.7 0.7 0.4 14 14 14 14 14 15 13 1.0 1.0 5.1 2.9 0.9 4.5 6.9 2.7 0.7 0.6 68 68 69 0.5 2.0 2.3 2.4 22 30 32 1.0 1.0 0.9
1.9 2.6 2.1 1.4 1.6 0.7 0.8 1.1 1.8 1.9 2.3 1.6 1.5 1.5 0.9 0.6 1.4 0.9 3.8 7.7 11 4.8 1.4 3.4 1.4 5.0 3.9 1.9 9.6 2.7 3.6 1.7 1.6 0.5 5.6 7.6 3.2 1.1 5.5 33
8.8 8.2 1.1 13 14 14 14 12 12 13 13 – – 0.2 0.2 0.8 0.6 0.5 0.2 67 0.4 0.3 67 67 67 0.2 68 0.1 0.1 0.0 68 67 67 67 147 140 134 165 167 167
67 69 77 68 66 64 62 100 93 89 93 86 77 73 64 60 135 146 596 576 560 547 534 664 625 605 593 583 572 557 542 523 505 489 470 474 469 466 448 273
-374 -377 -383 -393 -397 -401 -404 -415 -422 -429 -435 -443 -451 -458 -467 -473 -480 -498 -508 -526 -541 -557 -573 -586 -630 -655 -673 -687 -703 -722 -740 -761 -783 -800 -822 -820 -828 -834 -856 -1,033
0.2 0.3 0.6 0.8 0.8 1.1 1.1 1.6 8.1 8.6 10 12 13 14 14 15 77 120 184 198 199 202 202 210 237 237 237 237 240 240 241 239 239 239 232 237 233 234 237 237

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?